Knott David M Jr »

Inozyme Pharma shares owned by Knott David M Jr

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.9M 454k 4.20
2023-06-30 $1.2M 220k 5.57
2023-03-31 $917k 160k 5.73

More positions owned by Knott David M Jr

Calumet Specialty Products Partners Common (CLMT)
Apollo Global Management Common (APO)
FTAI Aviation Common (FTAI)
Alphabet Inc-Cl C Common (GOOG)
DocGo Common (DCGO)
Midwest Holding Common
Ligand Pharmaceuticals Incorporated Common (LGND)
Ardelyx Common (ARDX)
Coliseum Acquisition Corp. Wts Common (MITAW)
OmniAb Common (OABI)
CALLS/Calumet Specialty Product @20 ex1/24 Common
Franklin BSP Realty Trust Common (FBRT)
Seagen Common
Pfizer Common (PFE)
Panagram BBB-B CLO ETF Common (CLOZ)

View all positions for Knott David M Jr

Top funds holding Inozyme Pharma

Samlyn Capital
Eventide Asset Management
NEA Management Company
Vanguard Group
Sphera Funds Management
Samsara BioCapital
Blue Owl Capital Holdings
Millennium Management
Laurion Capital Management
Octagon Capital Advisors
Goldman Sachs Group
Kennedy Capital Management
Overbrook Management Corp.
Citadel Advisors
GSA Capital Partners

View all funds holding Inozyme Pharma